2024年11月,美国VBI Vaccines公司宣布:公司破产终止运营。VBI Vaccines公司总部位于美国马萨诸塞州剑桥市,公司拥有专有包膜VLP(“eVLP”)平台技术,用于开发模仿病毒自然表现的候选疫苗,以靶向和克服重大传染病,包括乙型肝炎、冠状病毒和巨细胞病毒(CMV)以及包括胶质母细胞瘤(GBM)在内的侵袭性癌症。2021年12月1日,VBI Vaccines公司宣布,美国FDA已...
Source Link2024年11月,美国VBI Vaccines公司宣布:公司破产终止运营。VBI Vaccines公司总部位于美国马萨诸塞州剑桥市,公司拥有专有包膜VLP(“eVLP”)平台技术,用于开发模仿病毒自然表现的候选疫苗,以靶向和克服重大传染病,包括乙型肝炎、冠状病毒和巨细胞病毒(CMV)以及包括胶质母细胞瘤(GBM)在内的侵袭性癌症。2021年12月1日,VBI Vaccines公司宣布,美国FDA已...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.